To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:232 Issue:1 Number:2 ISSN#:2564-2537
DOWNLOAD ESPAÑOL
RCT
ACE Report #14597
Ace Report Cover Physical Therapy & Rehab

AAOS 2022: Telerehabilitation vs. In-Office Rehabilitation After Arthroscopic Meniscectomy


How to Cite

OrthoEvidence. AAOS 2022: Telerehabilitation vs. In-Office Rehabilitation After Arthroscopic Meniscectomy. ACE Report. 2022;232(1):2. Available from: https://myorthoevidence.com/AceReport/Report/14597

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

There is No Difference in Early Functional Outcomes for Patients Undergoing TeleRehabilitation vs. Standard in Office Rehab after Arthroscopic Meniscectomy: A Randomized Controlled Trial

Contributing Authors:
Edward Mojica E Hurley K Vasavada C Lin G Gonzalez-Lomas MJ Alaia EJ Strauss LM Jazrawi KA Campbell

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

60 patients were included in the interim analysis of a randomized trial comparing telerehabilitation and in-person rehabilitation. Outcomes of interest included the International Knee Documentation Committee (IKDC) and Visual Analog Scale (VAS) scores, measured at 3, 6 and 12 months post-operation. Results revealed no significant differences between the two groups in both outcomes up to 6 months p...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.